lenalidomida alvogen 7,5 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 7,5mg - imunosupresoare alte imunosupresoare
lenalidomida labormed 2,5 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 2,5mg - imunosupresoare alte imunosupresoare
lenalidomida labormed 20 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 20mg - imunosupresoare alte imunosupresoare
lenalidomida labormed 7,5 mg
pharmadox healthcare ltd. - malta - lenalidomidum - caps. - 7,5mg - imunosupresoare alte imunosupresoare
pazopanib adalvo 200 mg
alvogen malta (out-licensing) ltd./amol ltd. - malta - pazopanib - compr. film. - 200mg - inhibitori de protein-kinaza
tremfya
janssen-cilag international nv - guselkumab - psoriazis - imunosupresoare - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.
comirnaty 30 mcg/doză concentrat pentru dispersie injectabilă
biontech manufacturing gmbh - combinaţie - concentrat pentru dispersie injectabilă - 30 mcg/doză
aclasta solutie perfuzabila 5 mg/100 ml
novartis pharma ag - acidum zoledronicum - solutie perfuzabila - 5 mg/100 ml
simdax 2,5 mg/ml
orion corporation - finlanda - levosimendanum - conc. pt. sol. perf. - 2,5mg/ml - stimulante cardiace excl. glicozizi cardiotonici alte stimulante cardiace
vicks antigrip complex 500 mg/200 mg/10 mg
procter & gamble manufacturing gmbh - germania - combinatii (paracetamolum+guaifenesinum+phenylephrinum) - pulb. pt. sol. orala - 500mg/200mg/10mg - alte combinatii pt. trat. racelii alte combinatii pt. trat. racelii